** Medical device maker Nevro Corp's shares NVRO.N rise 14.1% to $5.73, while Globus Medical GMED.N shares fall 4.5% to $88.22
** Globus Medical to acquire all shares of Nevro in an all-cash transaction, representing a total equity value of ~$250 million
** Deal offers $5.85 per share for each share of Nevro Corp, a premium of 16.5% to NVRO's last close
** Deal is expected to close late in Q2 2025
** In the last 12 months, GMED up 58.88%, while NVRO has fallen 60.78%
(Reporting by Siddhi Mahatole)
((siddhiprabhanjan.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.